Drug class
Carbapenem beta-lactam antibacterial; used clinically with cilastatin
Mechanism of action
Binds penicillin-binding proteins and inhibits bacterial cell-wall peptidoglycan synthesis, producing bactericidal activity. Cilastatin inhibits renal dehydropeptidase-I and prevents renal metabolism of imipenem; the fixed combination is used for systemic antibacterial therapy.
General use cases
- Treatment of serious infections caused by susceptible bacteria, including selected intra-abdominal, lower respiratory-tract, urinary-tract, gynaecological, skin/soft-tissue, bone/joint and septicaemia infections; current local antimicrobial guidance and susceptibility testing apply
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
